Van Meter, Anna R.
Algorta, Guillermo Perez
Youngstrom, Eric A.
Lechtman, Yana
Youngstrom, Jen K.
Feeny, Norah C.
Findling, Robert L.
Funding for this research was provided by:
National Institute of Mental Health (R01 MH066647)
Stanley Medical Research Institute
Article History
Received: 23 May 2016
Accepted: 19 July 2017
First Online: 26 July 2017
Compliance with ethical standards
:
: Dr. Feeny has no conflict of interest to report. Dr. Findling receives or has received research support, acted as a consultant and/or served on a speaker’s bureau for Actavis, Akili, Alcobra, American Academy of Child & Adolescent Psychiatry, American Psychiatric Press, Bracket, CogCubed, Cognition Group, Coronado Biosciences, Elsevier, Epharma Solutions, Forest, Genentech, GlaxoSmithKline, Guilford Press, Ironshore, Johns Hopkins University Press, KemPharm, Lundbeck, Medgenics, Merck, NIH, Neurim, Novartis, Otsuka, PCORI, Pfizer, Physicians Postgraduate Press, Purdue, Rhodes Pharmaceuticals, Roche, Sage, Shire, Sunovion, Supernus Pharmaceuticals, Syneurx, Takeda, Teva, TouchPoint, Tris, Validus, and WebMD. Ms. Lechtman has no conflict of interest to report. Dr. Perez Algorta has no conflict of interest to report. Dr. Van Meter has no conflict of interest to report. Dr. J. Youngstrom has no conflict of interest to report. Dr. E. Youngstrom has consulted with Pearson, Janssen, Otsuka, Lundbeck, and Western Psychological Services about psychological assessment.